Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
ONCS OncoSec Medical
2.100-0.100-4.55%
Trading Session
02/01 13:51 ET
High
2.163
Open
2.160
Turnover
97.98K
Low
2.030
Pre Close
2.200
Volume
47.60K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
OncoSec Medical Incorporated (NASDAQ:ONCS) Short Interest Down 60.2% in December
OncoSec Medical Incorporated (NASDAQ:ONCS – Get Rating) saw a large decline in short interest in December. As of December 30th, there was short interest totalling 45,700 shares, a decline of 60.2% f
Peering Into OncoSec Medical's Recent Short Interest
OncoSec Medical's (NASDAQ:ONCS) short percent of float has fallen 60.19% since its last report. The company recently reported that it has 45 thousand shares sold short, which is 2.07% of all regular s
StockNews.com Initiates Coverage on OncoSec Medical (NASDAQ:ONCS)
Analysts at StockNews.com started coverage on shares of OncoSec Medical (NASDAQ:ONCS – Get Rating) in a research report issued on Sunday. The firm set a "sell" rating on the biotechnology company's s
ONCS, TMBR and TUSK Among Mid-day Movers
12 Health Care Stocks Moving In Monday's Intraday Session
GainersDermata Therapeutics (NASDAQ:DRMA) shares increased by 101.8% to $0.4 during Monday's regular session. As of 12:30 EST, this security is trading at a volume of 44.7 million shares, making up 53
OncoSec Medical (NASDAQ:ONCS) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of OncoSec Medical (NASDAQ:ONCS – Get Rating) in a research note released on Thursday. The firm issued a sell rating on the biotechnology company's stock. Separ
Stocks That Hit 52-Week Lows On Thursday
 On Thursday, 241 companies hit new 52-week lows. Significant Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Tesla (NASDAQ:TSLA).Versus Systems (NA
OncoSec Medical (NASDAQ:ONCS) Coverage Initiated at StockNews.com
Investment analysts at StockNews.com assumed coverage on shares of OncoSec Medical (NASDAQ:ONCS – Get Rating) in a research note issued to investors on Thursday. The firm set a "sell" rating on the b
OncoSec Medical (NASDAQ:ONCS) Earns Sell Rating From Analysts at StockNews.com
StockNews.com started coverage on shares of OncoSec Medical (NASDAQ:ONCS – Get Rating) in a research note released on Wednesday. The brokerage issued a sell rating on the biotechnology company's stoc
Humanigen (NASDAQ:HGEN) and OncoSec Medical (NASDAQ:ONCS) Financial Comparison
Humanigen (NASDAQ:HGEN – Get Rating) and OncoSec Medical (NASDAQ:ONCS – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses base
Company Overview
More
OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered in Pennington, NJ.
CEO： Mr. Robert H. Arch
Market： NASDAQ
Listing Date： 05/29/2015
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet